372 results
8-K
EX-99.1
ACORQ
Acorda Therapeutics Inc
24 May 24
Regulation FD Disclosure
8:24am
: Payroll & Benefits (2,392,379) Gross to Net Disbursements (269,205) Inventory Purchases (24,514) Other Operating Disbursements (3,458,753) Total … Receipts 35,458 Total Receipts 4,328,132 Operating Disbursements: Payroll & Benefits - Gross to Net Disbursements (125,124) Inventory Purchases (339,793
8-K
EX-99.1
ACORQ
Acorda Therapeutics Inc
17 Apr 24
Acorda Therapeutics Announces Delisting from Nasdaq
9:10am
in jurisdictions outside of the U.S.; the ability to realize the benefits anticipated from acquisitions because, among other reasons, acquired development
8-K
EX-99.1
oextn
1 Apr 24
Acorda Therapeutics and Merz Announce Signing of “Stalking Horse” Asset Purchase Agreement
8:12pm
8-K
EX-99.1
xu1xo8q7vfk tll
11 Jan 24
Termination of a Material Definitive Agreement
8:33am
8-K
EX-99.1
xf1jq9txc1v6njft 4lg
13 Nov 23
Acorda Therapeutics Reports Third Quarter 2023 Financial Results
4:16pm
8-K
EX-99.1
6usl vy48y716om
8 Aug 23
Acorda Therapeutics Reports Second Quarter 2023 Financial Results
4:12pm
8-K
EX-99.1
1q8k4904j3t68
26 Jun 23
Other Events
4:30pm
8-K
EX-99.1
ibado
2 Jun 23
Acorda Therapeutics Announces Completion of 1-for-20 Reverse Stock Split
4:28pm
8-K
EX-99.1
cgupab0y416
31 May 23
Other Events
5:07pm